# EAGLE PHARMACEUTICALS INC (EGRX)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/EGRX/

- Reporting holders: 2
- Reported value: $8.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Stanley-Laman Group, Ltd.](https://holderbook.com/funds/1601489-stanley-laman-group-ltd/) | $8.0K | 12,000 | 0.0% | 31 |
| [Archer Investment Corp](https://holderbook.com/funds/1803804-archer-investment-corp/) | $470 | 700 | 0.0% | 14 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $8.5K |
| Q1 2026 | 2 | $4.2K |
| Q4 2025 | 2 | $8.6K |
| Q3 2025 | 2 | $33.3K |
| Q2 2025 | 2 | $35.8K |
| Q1 2025 | 2 | $12.1K |
| Q4 2024 | 9 | $38.8K |
| Q3 2024 | 65 | $35.7M |
| Q2 2024 | 77 | $77.8M |
| Q1 2024 | 92 | $59.2M |
| Q4 2023 | 103 | $54.9M |
| Q3 2023 | 107 | $162.9M |